Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
Xenon Pharmaceuticals Inc. (XENE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 25,000 shares
@ $38.7, valued at
$967.5k
|
|
| 08/10/2023 |
4
| Gover Justin D. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 28,000 options to buy
@ $38.39, valued at
$1.1M
|
|
| 08/10/2023 |
3
| Gover Justin D. (Director) has filed a Form 3 on Xenon Pharmaceuticals Inc. |
| 08/10/2023 |
4
| Cannon Gillian (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 28,000 options to buy
@ $38.39, valued at
$1.1M
|
|
| 08/10/2023 |
3
| Cannon Gillian (Director) has filed a Form 3 on Xenon Pharmaceuticals Inc. |
| 06/02/2023 |
4
| AZAB MOHAMMAD (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| PATOU GARY (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| GAROFALO ELIZABETH A. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/02/2023 |
4
| Machado Patrick (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 06/01/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 18,006 shares
@ $38.63, valued at
$695.6k
Sold 19,000 shares
@ $39.9, valued at
$758.1k
Sold 12,000 shares
@ $38.53, valued at
$462.4k
Exercised 29,835 shares
@ $9.85, valued at
$293.9k
Paid exercise price by delivering 6,165 shares
@ $38.37, valued at
$236.6k
Sold 23,670 shares
@ $38.81, valued at
$918.6k
Paid exercise price by delivering 23,144 shares
@ $38.37, valued at
$888k
Sold 26,856 shares
@ $38.69, valued at
$1M
Paid exercise price by delivering 1,860 shares
@ $38.53, valued at
$71.7k
Sold 7,458 shares
@ $38.97, valued at
$290.6k
Paid exercise price by delivering 20,745 shares
@ $38.53, valued at
$799.3k
|
|
| 05/26/2023 |
4
| MORTIMER IAN (PRESIDENT & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 42,592 shares
@ $9.44, valued at
$402.1k
Paid exercise price by delivering 7,310 shares
@ $41.84, valued at
$305.9k
Sold 17,069 shares
@ $41.44, valued at
$707.3k
Exercised 20,576 shares
@ $9.85, valued at
$202.7k
Paid exercise price by delivering 3,902 shares
@ $41.84, valued at
$163.3k
Sold 13,179 shares
@ $41.37, valued at
$545.2k
Exercised 6,172 shares
@ $9.85, valued at
$60.8k
Paid exercise price by delivering 1,171 shares
@ $41.84, valued at
$49k
Sold 1,407 shares
@ $41.49, valued at
$58.4k
Exercised 42,592 options to buy
@ $0
Exercised 20,576 options to buy
@ $0 |
|
| 03/24/2023 |
4
| KENNEY CHRISTOPHER JOHN (Chief Medical Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 700 shares
@ $35.01, valued at
$24.5k
|
|
| 03/14/2023 |
4
| Von Seggern Christopher (Chief Commercial Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 90,000 options to buy
@ $34.18, valued at
$3.1M
|
|
| 03/14/2023 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $34.18, valued at
$2.6M
|
|
| 03/14/2023 |
4
| DiFabio Andrea (Chief Legal Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 45,000 options to buy
@ $34.18, valued at
$1.5M
|
|
| 03/14/2023 |
4
| MORTIMER IAN (PRESIDENT & CEO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 380,000 options to buy
@ $34.18, valued at
$13M
|
|
| 03/14/2023 |
4
| KENNEY CHRISTOPHER JOHN (Chief Medical Officer) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 120,000 options to buy
@ $34.18, valued at
$4.1M
|
|
| 03/14/2023 |
4
| EMPFIELD JAMES R. (EVP, Drug Discovery) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 75,000 options to buy
@ $34.18, valued at
$2.6M
|
|
| 03/14/2023 |
4
| AULIN SHERRY (CFO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 120,000 options to buy
@ $34.18, valued at
$4.1M
|
|
| 03/09/2023 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Exercised 41,152 shares
@ $2.68, valued at
$110.3k
Paid exercise price by delivering 2,160 shares
@ $37.13, valued at
$80.2k
Sold 10,990 shares
@ $37.01, valued at
$406.7k
Exercised 30,864 shares
@ $2.59, valued at
$79.9k
Paid exercise price by delivering 1,618 shares
@ $37.13, valued at
$60.1k
Sold 8,242 shares
@ $36.94, valued at
$304.5k
Exercised 41,152 options to buy
@ $0
Exercised 30,864 options to buy
@ $0 |
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/07/2022 |
4
| AULIN SHERRY (CFO) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 3,293 shares
@ $39.53, valued at
$130.2k
Sold 15,355 shares
@ $39.57, valued at
$607.6k
Exercised 9,000 options to buy
@ $9.44, valued at
$85k
Exercised 32 options to buy
@ $7.49, valued at
$239.7
Exercised 813 options to buy
@ $8.4, valued at
$6.8k
Exercised 2,292 options to buy
@ $3.1, valued at
$7.1k
Exercised 6,511 options to buy
@ $4.75, valued at
$30.9k
|
|
| 09/02/2022 |
4
| ROBIN SHERRINGTON (EVP, Strategy & Innovation) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Paid exercise price by delivering 1,572 shares
@ $37.86, valued at
$59.5k
Sold 21,352 shares
@ $38.57, valued at
$823.5k
Paid exercise price by delivering 6,121 shares
@ $38.81, valued at
$237.6k
Sold 35,103 shares
@ $38.03, valued at
$1.3M
Sold 8,776 shares
@ $38.8, valued at
$340.5k
Exercised 17,488 options to buy
@ $2.67, valued at
$46.7k
Exercised 5,000 options to buy
@ $4.75, valued at
$23.8k
Exercised 50,000 options to buy
@ $4.75, valued at
$237.5k
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 43,135 shares
@ $37.91, valued at
$1.6M
Sold 47,000 shares
@ $38.6, valued at
$1.8M
Sold 1,000 shares
@ $39.15, valued at
$39.2k
Sold 33,942 shares
@ $37.76, valued at
$1.3M
Sold 32,058 shares
@ $38.29, valued at
$1.2M
Sold 20,000 shares
@ $38.87, valued at
$777.4k
|
|
| 06/29/2022 |
4
| PIMSTONE SIMON N. (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,000 options to buy
@ $30.11, valued at
$542k
|
|
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|